Acta Neuropharmacologica››2016,Vol. 6››Issue (4): 31-36.DOI:10.3969/j.issn.2095-1396.2016.04.005
Previous ArticlesNext Articles
ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong
Online:2016-08-26Published:2016-08-31Contact:陈乃宏，男，研究员，博士生导师；研究方向：分子神经药理学、中药药理学；Tel/Fax：+86-010-63165177，E-mail：chennh@imm.ac.cnAbout author:张小玲，女，博士研究生；研究方向：神经药理学和神经生物学；E-mail：zhangxiaoling@imm.ac.cnSupported by:
国家自然科学基金项目（No.81573636、No.U1402221、No.81560663），北京协和医学院“协和青年基金”项目（No.3332016058），中央级公益性科研院所基本科研业务费专项资金项目（No.2014RC03、No.2016RC350002），湖南省教育厅高校科研经费开放基金项目（No.15K091）
ZHANG Xiao-ling，WANG Zhen-zhen，WEN Lu，SHAO Qian-hang，CHEN Nai-hong.The Relationship between Cytokines and Depression[J]. Acta Neuropharmacologica, 2016, 6(4): 31-36.
| [1] Greden J F. The burden of disease for treatment-resistant depression [J]. J Clin Psychiatry, 2001, 62(16): 26-31. [2] Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study [J]. Lancet, 1997, 349 (9064): 1498-1504. [3] Ronald C Kessler. The costs of depression [J].Psychiatr Clin North Am, 2012, 35(1): 1-14. [4] Adrian J Dun, Artur H Swiergiel. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice [J]. Pharmacol Biochem Behav, 2005, 81(3): 688-693. [5] Andrey M Mazarati, Eduardo Pineda, Don Shin, et al. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1β [J]. Neurobiol Dis, 2010, 37(2): 461-467. [6] Donn A Simmons, Patricia A Broderick. Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(5):793-807. [7] Nicole Lichtblau, Frank Martin Schmidt, Robert Schumann, et al. Cytokines as biomarkers in depressive disorder: current standing and prospects [J]. Int Rev Psychiat, 2013, 25(5): 592-603. [8] Amisha Patel. Review: the role of inflammation in depression [J]. Psychiatria Danubina, 2013, 25(2): 216-223. [9] Sinead M O Brien, Lucinda V Scott, Timothy G Dinan. Cytokines: abnormalities in major depression and implications for pharmacological treatment [J]. Hum Psychopharmacol, 2004, 19(6): 397-403. [10] Olga J G Schiepers, Marieke C Wichers, Michael Maes. Cytokines and major depression [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(2): 201-217. [11] 徐说，林文娟．抗炎性细胞因子与抑郁症 [J]. 生物化学与生物物理进展，2014，41(11) : 1099-1108． [12] 苑杰，严辞，刘昊，等．抑郁症生物标志物研究进展 [J]．国际精神病学杂志，2015，42(2) : 103-107. [13] Ja Woo Koo, Ronald S Duman. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress [J]. Proc Natl Acad Sci U S A, 2008, 105(2): 751-756. [14] Greg Norman, Kate Karelina, Zhang N, et al. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury [J]. Mol Psychiatry, 2010, 15(4): 404-414. [15] Anna Gadek-Michalska, Joanna Tadeusz, Paulina Rachwalska, et al. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems [J]. Pharmacol Rep, 2013, 65 (6): 1655-1662. [16] Levine J, Barak Y, Chengappa K N, et al. Cerebrospinal cytokine levels in patients with acute depression [J]. Neuropsychobiology, 1999, 40(4): 171-176. [17] Owen B M, Eccleston D, Ferrier I N, et al. Raised levels of plasma interleukin-1beta in major and postviral depression [J]. Acta Psychiatr Scand, 2001, 103 (3): 226-228. [18] Brambilla F, Maurizio Maggioni. Blood levels of cytokines in elderly patients with major depressive disorder [J]. Acta Psychiatr Scand, 1998, 97 (4): 309-313. [19] Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al. A meta-analysis of cytokines in major depression [J]. Biol Psychiatry, 2010, 67(5): 446-457. [20] Ariyuki Kagaya, Akira Kugaya, Minoru Takebayashi, et al. Plasma concentrations of interleukin-1beta, interleukin-6 soluble interleukin-2 receptor and tumor necrosis factor alpha of depresse patients in Japan [J]. Neuropsychobiology, 2001, 43(2): 59-62. [21] Jose M Martinez, Amir Garakani, Rachel Yehuda, et al. Proinflammatory and “resiliency” proteins in the CSF of patients with major depression [J]. Depress Anxiety, 2012, 29(1): 32-38. [22] Rai Khalid Farooq, Elsa Isingrini, Arnaud Tanti, et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? [J]. Behav Brain Res, 2012, 231 (1): 130-137. [23] Cecile Mormede, Nathalie Castanon, Chantal Medina, et al. Chronic mild stress in mice decreases peripheral cytokine and increases central cytokine expression independently of IL-10 regulation of the cytokine network [J]. Ann NY Acad Sci, 2002, 10 (6): 359-366. [24] Ghanshyam N Pandey, Hooriyah S Rizavi, Ren Xin-guo, et al. Proin?ammatory cytokines in the prefrontal cortex of teenage suicide victims [J]. J Psychiatr Res, 2012, 46 (1): 57-63. [25] You Zi-li, Luo Chun-mei, Zhang Wen-zheng, et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression [J]. Behav Brain Res, 2011, 225 (1): 135-141. [26] Nicholas J Van Wagoner, Etty N Benveniste. Interleukin-6 expression and regulation in astrocytes [J]. J Neuroimmunol, 1999, 100(1-2):124-39. [27] Willscott E Naugler, Michael Karin. The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer [J]. Trends Mol Med, 2008, 14(3):109-119. [28] Goldstein B I, Kemp D E, Soczynska J K, et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature [J]. J Clin Psychiatry, 2009, 70(8):1078-1090. [29] Howren M Bryant, Lamkin Donald M, Suls Jerry. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis [J]. Psychosom Med, 2009, 71(2):171-186. [30] Eric P Zorrilla, Lester Luborsky, James R McKay, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review [J]. Brain Behav Immun, 2001, 15(3):199-226. [31] Michael Maes, Herbert Y Meltzer, Eugene Bosmans, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression [J]. J Affect Disord, 1995, 34(4):301-309. [32] Petr Bob, Jiri Raboch, Michael Maes, et al. Depression, traumatic stress and interleukin-6 [J]. J Affect Disord, 2010, 120(1-3):231-234. [33] Su Shao-yong, Andrew H Miller, Harold Snieder, et al. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study[J]. Psychosom Med, 2009, 71(2):152-158. [34] Daniel Lindqvist, Shorena Janelidze, Pater Hagell, et al Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity [J]. Biol Psychiatry, 2009, 66(3):287-292. [35] Shorena Janelidze, Daniele Mattei, Asa Westrin, et al. Cytokine levels in the blood may distinguish suicide attempters from depressed patients [J]. Brain Behav Immun, 2011, 25(2):335-339. [36]Sabine Chourbaji, Alexandre Urani, Ioana Inta, et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors [J]. Neurobiol Dis, 2006, 23(3):587-594. [37] Klemen Strle, Zhou Jian-hua, Wen H Shen, et al. lnterleukin-10 in the brain [J]. Critical Reviews TM in Immunology, 2001, 21(5):427-449. [38]Song C, Halbreich U, Han C, et al. Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients:the effect of electroacupuncture or fluoxetine treatment [J]. Pharmacopsychiatry, 2009, 42(05): 182-188. [39] Firdaus S Dhabhar, Heather M Burke, Elissa S Epel, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression [J]. J Psychiat Res, 2009, 43(11): 962-969. [40] Pan Yu-qin, Lin Wen-juan, Wang Wei-wen, et al. The effects of central pro-and anti-inflammatory immune challenges on depressive-like behavior induced by chronic forced swim stress in rats [J]. Behavi Brain Res, 2013, 247: 232-240 [41] Levent Sutcigil, Cagatay Oktenli, Ugur Musabak, et al. Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy [J]. Clin Develop Immunol, 2007, 2007: 76396 [42] Fili Fazzino, Francisco Obregón, Margarita Morles, et al. Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy [J]. Adv Exp Med Biol, 2009, 643: 217-224. [43] Ashley M Fenn, Christopher J Henry, Huang Yan, et al. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice [J]. Brain Behav Immun, 2012, 26(5): 766-777. [44] Godbout J P, Fenn A, Huang Y, et al. Central interleukin-4 infusion after a peripheral lipopolysaccharide injection promotes a neuroprotective CNS environment with increased M2 microglia [J]. Brain Behav Immun, 2012, 26(1): S29-S30. [45] Brian E Leonard. Inflammation, depression and dementia: are they connected?[J].Neurochem Res, 2007, 32(10): 1749-1756. [46] Simon N M, McNamara K, Chow C W, et al. A detailed examination of cytokine abnormalities in Major Depressive Disorder [J]. Euro Neuropsychopharmacol, 2008, 18(3): 230-233. [47] Fred D Finkelman, Terez Shea-Donohue, Suzanne C Morris, et al. Interleukin-4 and interleukin-13 mediated host protection against intestinal nematode parasites [J]. Immunol Rev, 2004, 201(1): 139-155. [48] Hymie Anisman, Zul Merali, Michael Owen Poulter, et al. Cytokines as a precipitant of depressive illness: animal and human studies [J]. Curr Pharm Des, 2005, 11(8): 963-972. [49] Müller N, Schwarz M J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression [J]. Mol Psychiatry, 2007, 12: 988-1000. [50] Adam K Walker, Annemieke Kavelaars, Heijen C J, et al. Neuroin?ammation and comorbidity of pain and depression [J]. Pharmacol Rev, 2013, 66 (1): 80-101. [51] Hideki Miura, Norio Ozaki, Makoto Sawada, et al. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression [J]. Stress, 2008, 11(3): 198-209. [52] Zhang Kun, Xu Hai-yun, Cao Long-long, et al. Interleukin-1β inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons[J]. Brain Res, 2012, 1490: 193-201. [53] Manocha M, Shajib MS, Rahman MM, et al. IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut[J]. Mucosal Immunology, 2012, 6(1): 146-155. [54] Zhu Chong-bin, Randy D Blakely, William A Hewlett. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters [J]. Neuropsychopharmacology, 2006; 31(10):2121-2131. [55] Wichers M C, Kenis G, Koek G H, et al. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol [J]. J Psychosom Res, 2007, 62(2): 207-214. [56] Benrick A，Schéle E，Pinnock S B，et al． Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei [J]．J Neuroendocrinol, 2009, 21(7): 620-628． [57] Marieke Wichers, Michael Maes. The role of indoleamine 2, 3 dioxygenase (IDO) in the pathophysiology of interferon-alpha- induced depression [J]. J Psychiatry Neurosci, 2004, 29 (1): 11-17. [58] Zhang Gong-liang, Zhao Bing-xue, Hua Rong, et al．Hippocampal microglial activation and glucocorticoid receptor down-regulation precipitate visceral hypersensitivity induced by colorectal distension in rats[J]. Neuropharmacology, 2016, 102:295-303. [59] Jennifer C Felger, Ebrahim Haroon, Bobbi J Woolwine, et al．Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus[J]. Physiol Behav, 2016, 166:14-21. |
| [1] | XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin.Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8. |
| [2] | MO Cui-ying, LUO Guo-ping.Influence of Nimergoline Combined with Trasylin and Psychotherapy for Depression in Patients with Post-stroke Depression[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 7-10. |
| [3] | FU Zhi-jiang1，GAO Yun2，ZHANG Wei3，LIU Zong-chao1，4，ZHANG Hua-wen4，LIU Shi-gui1，HUANG Chen-yi1，GAO Yin5，GAO Hai-ming1.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(6): 1-8. |
| [4] | FU Zhi-jiang1，LIU Yong1，GAO Yin1，ZHANG Wei2，GAO Yun2，LIU Zong-chao1*.Effects and Mechanisms of Depression on Bone Fracture Healing in Rats[J]. Acta Neuropharmacologica, 2018, 8(4): 5-6. |
| [5] | LIANG Jian-hui1,2*, LIANG hui2, CHENG tao1, LIU Xiao-yan1, Simon M.Y.Lee3, TANG Ben-qin3, WANG Xiu-fen3, CHEN Feng4,Andrew J. Lawrence4.Comorbidity of Anxiety and Depression Induced by Liang’s Contextual-Stress Box in Mice[J]. Acta Neuropharmacologica, 2018, 8(4): 44-45. |
| [6] | ZAN Gui-ying，SUN Xiang，LI Qing-lin，LIU Jing-gen.Research Progress of the Role and Underlying Mechanism of Dynorphin/κ Opioid Receptor in the Development of Depression[J]. Acta Neuropharmacologica, 2018, 8(1): 54-64. |
| [7] | LIANG Hui，CHENG Tao，LIANG Jian-hui.Progress in the Comorbidity of Depression and Anxiety[J]. Acta Neuropharmacologica, 2017, 7(6): 30-35. |
| [8] | ZHANG Kuo，YANG Jing-yu，WU Chun-fu.Progress on Pathophysiology and Animal Models of Depression[J]. Acta Neuropharmacologica, 2017, 7(4): 8-16. |
| [9] | REN Qian,WANG Zhen-zhen,CHEN Nai-hong.Regulation of Neuroplasticity by MicroRNA in Depression Disorder[J]. Acta Neuropharmacologica, 2017, 7(3): 12-20. |
| [10] | DU Guan-tao， LIN Jing-ran,LIU Guang-jun， HONG Hao.Research Progress on the Correlation Between Alzheimer’s Disease and Depression[J]. Acta Neuropharmacologica, 2016, 6(6): 40-44. |
| [11] | CAO Li-hua，BAI Ming，FANG Xiao-yan，WANG Can，MIAO Ming-san.Analysis of Animal Models of Depression Based on Clinical Symptoms[J]. Acta Neuropharmacologica, 2016, 6(4): 19-23. |
| [12] | WANG Sha-sha，ZHANG Zhao，ZHANG Mei-jin，HU Jin-feng，CHEN Nai-hong.Advances of Nrf 2/ARE Signaling Pathway in the Major Depression Disorder[J]. Acta Neuropharmacologica, 2016, 6(3): 32-37. |
| [13] | HE Hai-ran, XUE Zhan-xia.Research Progress in the Pathogenesis of Depression[J]. ACTA NEUROPHARMACOLOGICA, 2016, 6(2): 20-25. |
| [14] | JIANG Xiang-yun, SHANG Chao, LI Lei, SUN Shu-zheng, LI Yun-feng, WANG Heng-lin.Allopregnanolone as a New Therapeutic Target for Depression and Anxiety[J]. ACTA NEUROPHARMACOLOGICA, 2016, 6(2): 26-30. |
| [15] | HU Bao-ling, GUO Chun-yan.Advances Achievements about Neuroprotective Mechanisms of Paeoniflorin[J]. ACTA NEUROPHARMACOLOGICA, 2015, 5(6): 51-56. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
